![Company logo](https://db-fastly.legal.io/job/66a2e7ccb5e935addac6dcba/1722016147.webp?auto=webp)
Overview
The Senior Manager, Global Compliance Operations, will report to the Director of Global Compliance Monitoring and Anti-Bribery/Anti-Corruption (ABAC) Programs, and is responsible for the oversight, implementation and continuous improvement of compliance systems, tools, processes, and programs designed to identify and mitigate healthcare compliance risk, drive operational efficiency, and enhance the effectiveness of the Global Compliance program and the broader enterprise.
The Senior Manager will be responsible for helping advance Alnylam’s Global Compliance Program and enterprise efficiencies by partnering cross-functionally with stakeholders in Internal Audit, Finance, IT, and Legal to enhance compliance tools, controls and systems within an end-to-end procure-to-pay process, to optimize end-user experience. The Senior Manager will coordinate across the Ethics & Compliance organization, collaborating with key business stakeholders across the Company, and present to country-level, franchise and functional leadership. The Senior Manager must possess an innovative mindset and take a practical, solutions-oriented approach to: (1) leveraging technology to evolve, harmonize, streamline, and strengthen the Global Compliance program and the broader enterprise procure-to-pay process; (2) supporting Compliance business partners in carrying out their advisory responsibilities; and (3) enabling end-users in the broader business to conduct their daily work in a compliant, but efficient manner.
Key Responsibilities
The Senior Manager serves as a healthcare compliance risk SME in the management of tools with embedded compliance controls, specifically:
Qualifications
About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.
Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.
At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law.